Pacific Edge suffers another setback in US

Pacific Edge suffers another setback in US
(Image: Pacific Edge)
Staff reporters
Shares in cancer diagnostics company Pacific Edge are down 2.44% to $0.120 after another setback in the US market.The US District Court for the Middle District of Pennsylvania has determined that it does not have jurisdiction to review a Local Coverage Determination (LCD) that could end reimbursement for its CxBladder Triage, Detect and Monitor tests on April 24 in the US. LCDs are defined as decisions made by a Medicare administrative contractor on whether a service or item is reasonable and necessary, and therefore covered by Medicare wi...